238 related articles for article (PubMed ID: 22098563)
1. Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects.
Zanni MV; Burdo TH; Makimura H; Williams KC; Grinspoon SK
Clin Endocrinol (Oxf); 2012 Sep; 77(3):385-90. PubMed ID: 22098563
[TBL] [Abstract][Full Text] [Related]
2. The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss.
Fjeldborg K; Christiansen T; Bennetzen M; J Møller H; Pedersen SB; Richelsen B
Obesity (Silver Spring); 2013 Dec; 21(12):2437-43. PubMed ID: 23512476
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD163: a biomarker linking macrophages and insulin resistance.
Parkner T; Sørensen LP; Nielsen AR; Fischer CP; Bibby BM; Nielsen S; Pedersen BK; Møller HJ
Diabetologia; 2012 Jun; 55(6):1856-62. PubMed ID: 22450890
[TBL] [Abstract][Full Text] [Related]
4. The Macrophage Activation Marker Soluble CD163 is Longitudinally Associated With Insulin Sensitivity and β-cell Function.
Semnani-Azad Z; Connelly PW; Johnston LW; Retnakaran R; Harris SB; Zinman B; Hanley AJ
J Clin Endocrinol Metab; 2020 Mar; 105(3):e285-94. PubMed ID: 31677389
[TBL] [Abstract][Full Text] [Related]
5. Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults.
Reid M; Ma Y; Scherzer R; Price JC; French AL; Plankey MW; Grunfeld C; Tien PC
AIDS; 2017 Jan; 31(3):385-393. PubMed ID: 28081037
[TBL] [Abstract][Full Text] [Related]
6. The macrophage activation product sCD163 is associated with a less favourable metabolic profile in prepubertal children.
Carreras-Badosa G; Prats-Puig A; Diaz-Roldan F; Platero-Gutierrez E; Osiniri I; Riera-Perez E; de Zegher F; Ibañez L; Bassols J; López-Bermejo A
Pediatr Obes; 2016 Dec; 11(6):543-550. PubMed ID: 26843034
[TBL] [Abstract][Full Text] [Related]
7. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
Kazankov K; Tordjman J; Møller HJ; Vilstrup H; Poitou C; Bedossa P; Bouillot JL; Clement K; Grønbaek H
J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
[TBL] [Abstract][Full Text] [Related]
8. The Association between Monocyte Surface CD163 and Insulin Resistance in Patients with Type 2 Diabetes.
Kawarabayashi R; Motoyama K; Nakamura M; Yamazaki Y; Morioka T; Mori K; Fukumoto S; Imanishi Y; Shioi A; Shoji T; Emoto M; Inaba M
J Diabetes Res; 2017; 2017():6549242. PubMed ID: 29445750
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
[TBL] [Abstract][Full Text] [Related]
10. A Study of Serum Soluble CD 163 Levels in Women with Polycystic Ovary Syndrome.
Oruç AS; Yilmaz N; İnal HA; Görkem Ü; Gulsen P; Uğur M; Buyukkagnici U
Horm Metab Res; 2016 Jun; 48(6):399-403. PubMed ID: 26985764
[TBL] [Abstract][Full Text] [Related]
11. Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs.
Greisen SR; Møller HJ; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Hvid M; Deleuran B
Clin Exp Rheumatol; 2015; 33(4):498-502. PubMed ID: 25962601
[TBL] [Abstract][Full Text] [Related]
12. An alternatively activated macrophage marker CD163 in severely obese patients: the influence of very low-calorie diet and bariatric surgery.
Cinkajzlová A; Lacinová Z; Kloučková J; Kaválková P; Trachta P; Kosák M; Krátký J; Kasalický M; DoleŽalová K; Mráz M; Haluzík M
Physiol Res; 2017 Sep; 66(4):641-652. PubMed ID: 28406702
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD163 is associated with CD163 mRNA expression in adipose tissue and with insulin sensitivity in steady-state condition but not in response to calorie restriction.
Kračmerová J; Rossmeislová L; Kováčová Z; Klimčáková E; Polák J; Tencerová M; Mališová L; Štich V; Langin D; Šiklová M
J Clin Endocrinol Metab; 2014 Mar; 99(3):E528-35. PubMed ID: 24423341
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD163 is associated with body mass index and blood pressure in hypertensive obese Saudi patients.
Al-Daghri NM; Al-Attas OS; Bindahman LS; Alokail MS; Alkharfy KM; Draz HM; Yakout S; McTernan PG; Sabico S; Chrousos GP
Eur J Clin Invest; 2012 Nov; 42(11):1221-6. PubMed ID: 22946776
[TBL] [Abstract][Full Text] [Related]
16. Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163.
Møller HJ; Moestrup SK; Weis N; Wejse C; Nielsen H; Pedersen SS; Attermann J; Nexø E; Kronborg G
Crit Care Med; 2006 Oct; 34(10):2561-6. PubMed ID: 16915112
[TBL] [Abstract][Full Text] [Related]
17. Increased macrophage activation marker soluble CD163 is associated with graft dysfunction and metabolic derangements in renal transplant recipients.
El Aggan H; Mahmoud S; El Shair H; Elabd H
Biomed J; 2021 Dec; 44(6 Suppl 2):S179-S189. PubMed ID: 35300946
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort.
Deichgræber P; Witte DR; Møller HJ; Skriver MV; Richelsen B; Jørgensen ME; Johansen NB; Sandbæk A
Diabetologia; 2016 Nov; 59(11):2467-2476. PubMed ID: 27541014
[TBL] [Abstract][Full Text] [Related]
19. Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection.
Burdo TH; Weiffenbach A; Woods SP; Letendre S; Ellis RJ; Williams KC
AIDS; 2013 Jun; 27(9):1387-95. PubMed ID: 23435298
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.
Burdo TH; Lentz MR; Autissier P; Krishnan A; Halpern E; Letendre S; Rosenberg ES; Ellis RJ; Williams KC
J Infect Dis; 2011 Jul; 204(1):154-63. PubMed ID: 21628670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
